{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:53:26Z","timestamp":1648745606856},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T00:00:00Z","timestamp":1427760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12185-015-1786-0","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T23:29:16Z","timestamp":1427671756000},"page":"35-40","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy"],"prefix":"10.1007","volume":"102","author":[{"given":"Masamitsu","family":"Yanada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinao","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Inaguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masutaka","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaharu","family":"Kanie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Emi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"1786_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(61)90118-7","volume":"14","author":"EJ Freireich","year":"1961","unstructured":"Freireich EJ, Gehan EA, Sulman D, Boggs DR, Frei E 3rd. The effect of chemotherapy on acute leukemia in the human. J Chronic Dis. 1961;14:593\u2013608.","journal-title":"J Chronic Dis"},{"key":"1786_CR2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2006-08-041152","volume":"109","author":"FR Appelbaum","year":"2007","unstructured":"Appelbaum FR, Rosenblum D, Arceci RJ, Carroll WL, Breitfeld PP, Forman SJ, et al. End points to establish the efficacy of new agents in the treatment of acute leukemia. Blood. 2007;109:1810\u20136.","journal-title":"Blood"},{"key":"1786_CR3","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","volume":"113","author":"G Juliusson","year":"2009","unstructured":"Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179\u201387.","journal-title":"Blood"},{"key":"1786_CR4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97:1916\u201324.","journal-title":"Haematologica"},{"key":"1786_CR5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937\u201351.","journal-title":"Blood"},{"key":"1786_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354\u201365.","journal-title":"Blood"},{"key":"1786_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453\u201374.","journal-title":"Blood"},{"key":"1786_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12185-012-1146-2","volume":"96","author":"T Matsunaga","year":"2012","unstructured":"Matsunaga T, Yamashita K, Kubuki Y, Toyama T, Imataki O, Maeda K, et al. Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture. Jpn Int J Hematol. 2012;96:342\u20139.","journal-title":"Jpn Int J Hematol"},{"key":"1786_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.1954.tb40023.x","volume":"60","author":"H Tivey","year":"1954","unstructured":"Tivey H. The natural history of untreated acute leukemia. Ann N Y Acad Sci. 1954;60:322\u201358.","journal-title":"Ann N Y Acad Sci"},{"key":"1786_CR10","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1200\/JCO.2014.57.1034","volume":"32","author":"EJ Freireich","year":"2014","unstructured":"Freireich EJ, Wiernik PH, Steensma DP. The Leukemias: a half-century of discovery. J Clin Oncol. 2014;32:3463\u20139.","journal-title":"J Clin Oncol"},{"key":"1786_CR11","first-page":"485","volume":"57","author":"JW Yates","year":"1973","unstructured":"Yates JW, Wallace HJ Jr, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute non-lymphocytic leukemia. Cancer Chemother Rep. 1973;57:485\u20138.","journal-title":"Cancer Chemother Rep"},{"key":"1786_CR12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.1989.7.9.1268","volume":"7","author":"B Lowenberg","year":"1989","unstructured":"Lowenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol. 1989;7:1268\u201374.","journal-title":"J Clin Oncol"},{"key":"1786_CR13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.22496","volume":"109","author":"AK Burnett","year":"2007","unstructured":"Burnett AK, Milligan D, Prentice AG, Goldstone AH, McMullin MF, Hills RK, et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer. 2007;109:1114\u201324.","journal-title":"Cancer"},{"key":"1786_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-014-1617-8","volume":"100","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Cheong JW, Kim DY, Lee JH, Lee KH, Kim YK, et al. Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients. Int J Hematol. 2014;100:141\u201351.","journal-title":"Int J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-015-1786-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1786-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:21:29Z","timestamp":1566476489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-015-1786-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1786"],"URL":"https:\/\/doi.org\/10.1007\/s12185-015-1786-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,31]]}}}